LEADER 04015nam 2200601Ia 450 001 996205523103316 005 20230828225118.0 010 $a1-280-74802-8 010 $a9786610748020 010 $a0-470-98494-5 010 $a0-470-75317-X 010 $a1-4051-7176-6 035 $a(CKB)1000000000341952 035 $a(EBL)284234 035 $a(SSID)ssj0000119598 035 $a(PQKBManifestationID)11145646 035 $a(PQKBTitleCode)TC0000119598 035 $a(PQKBWorkID)10057426 035 $a(PQKB)11276765 035 $a(MiAaPQ)EBC284234 035 $a(OCoLC)212123339 035 $a(EXLCZ)991000000000341952 100 $a20051108d2006 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aChallenges in inflammatory bowel disease$b[electronic resource] /$fedited by Derek Jewell ... [et al.] 205 $a2nd ed. 210 $aOxford $cBlackwell$d2006 215 $a1 online resource (414 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-2234-X 320 $aIncludes bibliographical references and index. 327 $aInflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis? 327 $a7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 327 $a14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 327 $a26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index 330 $aReviews focused topics - both clinical and basic science - in the fast-moving area of IBD, providing emphasis on the current challenges faced in the successful management of the disease Turn to Challenges in Inflammatory Bowel Disease (IBD) when you need an expert opinion on the new, unusual or controversial areas of IBD and not just the tried and tested information. Current and concise reviews of the latest scientific discoveries are translated into cutting-edge clinical guidance to address those challenging cases faced by every medical team caring for patients with IBD. < 606 $aInflammatory bowel diseases 606 $aInternal medicine 615 0$aInflammatory bowel diseases. 615 0$aInternal medicine. 676 $a616.344 701 $aJewell$b D. P$0313992 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a996205523103316 996 $aChallenges in inflammatory bowel disease$93069386 997 $aUNISA